Medicaid Revenue Up in States With Medicaid Expansion

Share this content:
Medicaid Revenue Up in States With Medicaid Expansion
Medicaid Revenue Up in States With Medicaid Expansion

FRIDAY, Oct. 14, 2016 (HealthDay News) -- Hospitals in states that implemented Medicaid expansion in 2014 had a significant increase in Medicaid revenue, according to a study published in the Oct. 11 issue of the Journal of the American Medical Association.

In an effort to examine the correlation between Medicaid expansion in 2014 and hospital finances, Fredric Blavin, Ph.D., from the Urban Institute in Washington, D.C., conducted an observational study with analysis of data for nonfederal general medical or surgical hospitals in fiscal years 2011 to 2014. Data were included from a sample including 1,200 to 1,400 hospitals per fiscal year in 19 states with Medicaid expansion and for 2,200 to 2,400 hospitals per fiscal year in 25 states without Medicaid expansion.

Blavin found that Medicaid expansion correlated with a decrease of $2.8 million per hospital in mean annual uncompensated care costs (P < 0.001). Relative to hospitals in states without Medicaid expansion, hospitals in states with Medicaid expansions had an increase of $3.2 million in mean annual Medicaid revenue per hospital (P = 0.008). There was also a significant association for Medicaid expansion with improved excess margins (1.1 percentage points; 95 percent confidence interval, 0.1 to 2.0; P = 0.04), but no improvement in operating margins (1.1 percentage points; 95 percent confidence interval, −0.1 to 2.3 percentage points; P = 0.06).

"Further study is needed to assess longer-term implications of this policy change on hospitals' overall finances," Blavin writes.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »